Q3 2025 saw 11% sales growth and a 59% EBITDA increase year-over-year, driven by improved order intake and restructuring. Major contracts and acquisitions strengthened core segments, while ongoing restructuring and market gains support a positive outlook for year-end.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.